Mar 23, 2011 · Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide …

Masimo Corporation is an American health technology and consumer electronics company headquartered in Irvine, California. The company develops patient monitoring devices, non-invasive …

Feb 17, 2026 · Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation …

Jun 11, 2026 · Danaher closes $9.9B Masimo buyout CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.

Jun 10, 2026 · Danaher (NYSE:DHR) announced today that it completed its previously announced acquisition of Masimo (Nasdaq:MASI).

Jun 10, 2026 · Masimo completed a cash merger at $180 per share, cancelling all public equity. The merger ended Masimo’s Nasdaq listing, reshaped leadership, and settled key executive exits. …

Jun 11, 2026 · Danaher announced that it has completed the acquisition of Masimo, a specialty diagnostics provider of pulse oximetry and patient monitoring solutions, mainly in acute care …

Masimo SafetyNet supports people recovering at home with the same hospital-grade pulse oximetry technology, Masimo Signal Extraction Technology ® (SET ®), that is the primary pulse oximetry at 9 …

Feb 17, 2026 · Irvine’s Masimo selling to Danaher, Beckman Coulter owner, for $9.9 billion Danaher will pay $180 per share in cash for Masimo, close to a 40% premium over the closing share price on Friday.

Feb 17, 2026 · Danaher is acquiring Masimo in a $9.9 billion all-cash deal. Here’s what the acquisition means for DHR stock, Masimo’s Apple litigation, and long-term investors.